• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Mirati - oncology?

















































SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Mirati Therapeutics, Inc. (MRTX) and Encourages Long-Term MRTX Investors to Contact the Firm - Mirati Therapeutics (NASDAQ:MRTX) - Benzinga


https://www.benzinga.com/pressrelea...tion-of-mirati-therapeutics-inc-mrtx-and-enco

PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Mirati Therapeutics, Inc. MRTX on behalf of the company's long-term investors.

The investigation seeks to determine whether Mirati has issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company's shareholders.
 




SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Mirati Therapeutics, Inc. (MRTX) and Encourages Long-Term MRTX Investors to Contact the Firm - Mirati Therapeutics (NASDAQ:MRTX) - Benzinga


https://www.benzinga.com/pressrelea...tion-of-mirati-therapeutics-inc-mrtx-and-enco

PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Mirati Therapeutics, Inc. MRTX on behalf of the company's long-term investors.

The investigation seeks to determine whether Mirati has issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company's shareholders.

Everybody knows but nobody's saying nothing.
 




SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Mirati Therapeutics, Inc. (MRTX) and Encourages Long-Term MRTX Investors to Contact the Firm - Mirati Therapeutics (NASDAQ:MRTX) - Benzinga


https://www.benzinga.com/pressrelea...tion-of-mirati-therapeutics-inc-mrtx-and-enco

PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Mirati Therapeutics, Inc. MRTX on behalf of the company's long-term investors.

The investigation seeks to determine whether Mirati has issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company's shareholders.

Meek is sleazy and stupid. That’s usually not a winning combination.
 








SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Mirati Therapeutics, Inc. (MRTX) and Encourages Long-Term MRTX Investors to Contact the Firm - Mirati Therapeutics (NASDAQ:MRTX) - Benzinga


https://www.benzinga.com/pressrelea...tion-of-mirati-therapeutics-inc-mrtx-and-enco

PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Mirati Therapeutics, Inc. MRTX on behalf of the company's long-term investors.

The investigation seeks to determine whether Mirati has issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company's shareholders.
Thats what we were saiding!